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Cornichon-2 and cornichon-3 (CNIH-2/-3) are AMPA
receptor (AMPAR) binding proteins that promote
receptor trafficking and markedly slow AMPAR
deactivation in heterologous cells, but their role in
neurons is unclear. Using CNIH-2 and CNIH-3 condi-
tional knockoutmice, we find a profound reduction of
AMPAR synaptic transmission in the hippocampus.
This deficit is due to the selective loss of surface
GluA1-containing AMPARs (GluA1A2 heteromers),
leaving a small residual pool of synaptic GluA2A3
heteromers. The kinetics of AMPARs in neurons lack-
ing CNIH-2/-3 are faster than those in WT neurons
due to the fast kinetics of GluA2A3 heteromers. The
remarkably selective effect of CNIHs on the GluA1
subunit is probably mediated by TARP g-8, which
prevents a functional association of CNIHs with
non-GluA1 subunits. These results point to a
sophisticated interplay between CNIHs and g-8 that
dictates subunit-specific AMPAR trafficking and the
strength and kinetics of synaptic AMPAR-mediated
transmission.
INTRODUCTION
It is well established that auxiliary proteins play a critical role in
the trafficking and function of voltage-gated ion channels.
However, until recently, it was thought that ionotropic neuro-
transmitter receptors operated independently of auxiliary
subunits. This view changed with the discovery of the tetraspan-
ning membrane protein stargazin, the protein that is mutated
in the ataxic mouse stargazer. Cerebellar granule neurons
(CGNs), in which stargazin is highly expressed, lack surface
AMPA-type glutamate receptors (AMPARs) in the stargazer
mouse. In addition to controlling AMPAR trafficking, stargazinalso controls AMPAR gating, thus establishing it as a bona fide
AMPAR auxiliary subunit. Stargazin is a member of a family of
proteins termed transmembrane AMPAR regulatory proteins
(TARPs), which have both distinct and overlapping properties
to stargazin (Coombs and Cull-Candy, 2009; Dı´az, 2010; Jack-
son and Nicoll, 2011; Kato et al., 2010b; Straub and Tomita,
2012). Additional AMPAR auxiliary subunits, unrelated to TARPs,
have been identified from a variety of screens (Wang et al., 2008;
Zheng et al., 2004). Among these proteins are cornichon-2 and
cornichon-3 (CNIH-2 and CNIH-3, respectively) (Schwenk
et al., 2009). In expression systems, CNIH-2 markedly slows
AMPAR deactivation and desensitization and shares a number
of other properties with TARPs (Gill et al., 2011, 2012; Harmel
et al., 2012; Kato et al., 2010a; Schwenk et al., 2009; Shi et al.,
2010). However, in CGNs and hippocampal neurons, no sig-
nificant effect of CNIH-2 overexpression was observed on
AMPAR-mediated synaptic currents (Shi et al., 2010). Thus, it
was proposed that CNIH-2’s function in neurons was more
akin to its yeast and Drosophila homologs, which serve as chap-
erones in the forward trafficking of EGFR ligands from ER to
Golgi (Bo¨kel et al., 2006; Castillon et al., 2009). Additional studies
on CNIH-2 supported its role in forward trafficking of neuronal
AMPARs (Harmel et al., 2012) but concluded that CNIH-2 re-
mained bound to AMPARs on the surface of neurons (Gill
et al., 2011; Harmel et al., 2012; Kato et al., 2010a). Furthermore,
it was proposed that CNIH-2 displaced g-8, the primary TARP
expressed in the hippocampus, thus reducing TARP stoichiom-
etry (Gill et al., 2011, 2012; Kato et al., 2010a), which challenged
previous work suggesting that all possible g-8 binding sites on
native AMPARs were occupied (Shi et al., 2009).
In the present study, we have generated conditional CNIH-2
and CNIH-3 knockout (KO) mice to determine the roles of
CNIH-2 and CNIH-3 in excitatory synaptic transmission in the
hippocampus. We find that CNIHs play a critical role in sup-
porting AMPAR-mediated responses, because AMPAR function
is profoundly reduced in neurons lacking both CNIH-2 and
CNIH-3. However, importantly, CNIH-2/-3 binding to AMPARs
is dependent on AMPAR subunit composition and TARPs.
Four subunits (GluA1–GluA4) contribute to the formation ofNeuron 77, 1083–1096, March 20, 2013 ª2013 Elsevier Inc. 1083
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CNIH Proteins Determine AMPAR Subunit Compositiontetrameric AMPARs. We have previously shown that 80% of
synaptic AMPARs in CA1 pyramidal neurons are composed of
GluA1A2 heteromers, whereas the rest are GluA2A3 heteromers
(Lu et al., 2009). Here, our data reveal that CNIH-2/-3 selectively
bind to GluA1 in hippocampal neurons, allowing GluA1A2 recep-
tors to reach the surface, and suggest that CNIH-2/-3 interaction
with non-GluA1 subunits is prevented by g-8. Removal of
CNIH-2/-3 also speeds up the deactivation kinetics of surface
AMPARs, an effect attributable to the loss of GluA1A2 receptors,
which deactivate more slowly thanGluA2A3 receptors. Thus, our
data point to a model in which the trafficking and gating of indi-
vidual AMPARs are determined by the interplay of AMPAR
subunits, cornichons, and TARPs.
RESULTS
Genetic Deletion of CNIH-2 and CNIH-3
Cnih2fl/fl and Cnih3fl/fl mice were generated by standard proce-
dures (Figure S1 available online). Cnih2fl/fl and Cnih3fl/fl mice
were first bred as homozygotes, and then Cnih2fl/fl mice were
bred with Cnih3fl/flmice and NEX-CRE mice. Importantly, homo-
zygous Cnih2fl/fl and Cnih3fl/fl were indistinguishable from wild-
type mice. In addition, the NEX-CRE Cnih2fl/fl (NexCnih2/)
mice, in which CNIH-2 is deleted from all forebrain pyra-
midal neurons, appeared grossly normal, and breeding was
Mendelian.
Deletion of CNIH-2 Selectively Depresses AMPAR
Synaptic Transmission
We used three strategies to study the effects of deleting
CNIH-2. Using Cnih2fl/fl mice, we (1) injected AAV-CRE-GFP
into the hippocampus of postnatal day 0–2 (P0–P2) mouse
pups and then made acute slices 3 weeks later; (2) made
hippocampal slice cultures at P6–P9, biolistically transfected
neurons with CRE-GFP at 4 days in vitro (DIV), and recorded
2–3 weeks later (see Experimental Procedures for details);
and (3) crossed Cnih2fl/fl mice with the NEX-CRE mouse
line. In the first two sets of experiments, simultaneous record-
ings of AMPAR- and NMDAR-evoked excitatory postsynap-
tic currents (AMPAR- and NMDAR-eEPSCs, respectively)
were made from a green-infected/-transfected CA1 pyramidal
neuron expressing CRE and a neighboring control nongreen
pyramidal neuron during stimulation of excitatory axons in
stratum radiatum. This approach permitted a pairwise, inter-
nally controlled comparison of the consequence of our
genetic manipulation. In the third approach using acute slices
prepared from NexCnih2/ mice, the ratio of the AMPAR-
and NMDAR-eEPSCs was calculated and compared to wild-
type neurons.
CNIH-2 deletion in single neurons by P0–P2 injection (red
circles) and in slice culture (black circles) caused a 54%
reduction in AMPAR-eEPSCs (Figure 1A), but no change in
NMDAR-eEPSCs (Figure 1B). Because there was no significant
difference between the results from acute and cultured slices,
the data were combined. CNIH-2 deletion also caused
a speeding in the decay of AMPAR-EPSCs in acute slices. This
included eEPSCs (Figure 1C) and miniature EPSCs (mEPSCs)
(Figure 1E). Furthermore, mEPSC amplitude was reduced (Fig-1084 Neuron 77, 1083–1096, March 20, 2013 ª2013 Elsevier Inc.ure 1D), consistent with a reduction in AMPAR number at indi-
vidual synapses. The difference in the magnitude of amplitude
change between the evoked and mEPSCs can be explained by
the fact that a threshold is required for detecting mEPSCs, and
many events fall below this threshold in the absence of CNIH-
2. This is reflected in the large decrease in mEPSC frequency
(Figure S2A). To quantitatively determine the effects of CNIH-2
on AMPAR kinetics, we pulled somatic outside-out patches
and used ultrafast glutamate application to measure AMPAR
deactivation (Figure 1F) and desensitization (Figure 1G). Both
desensitization and deactivation time constants were faster in
the absence of CNIH-2. We also examined AMPAR currents
generated from somatic extrasynaptic outside-out patches in
the presence of cyclothiazide to block desensitization. Similar
to AMPAR-eEPSCs, extrasynaptic currents were reduced by
47% in CRE-infected neurons (Figure 1H). Furthermore, if
CNIH-2 reduces the stoichiometry of TARP g-8 binding to AM-
PARs as previously proposed by Gill et al. (2011) and Kato
et al. (2010a), then in the absence of CNIH-2, the g-8/AMPAR
stoichiometry should increase, and thus, the kainate/glutamate
(IKA/IGlu) ratio, a sensitive assay for g-8/AMPAR stoichiometry
(Shi et al., 2009), should also increase. However, no change in
IKA/IGlu was seen in neurons lacking CNIH-2 (Figure 1I). We
also observed no change in AMPAR-eEPSC rectification in the
absence of CNIH-2, indicating no change in GluA2 content (Fig-
ure S2B). CNIH-2 deletion also failed to influence paired-pulse
ratio, indicating an exclusively postsynaptic role for CNIH-2
(Figure S2C).
Deletion of CNIH-3 Selectively Depresses AMPAR
Synaptic Transmission when Combined with CNIH-2
Deletion
CNIH-3 is also expressed in hippocampus, although at a lower
level than CNIH-2 (Lein et al., 2007). We therefore analyzed
Cnih3fl/fl mice (Figures S1B and S1C). We found that deleting
CNIH-3 had no effect on AMPAR- or NMDAR-eEPSCs (Figures
2A and 2B), suggesting that either CNIH-3 is not expressed in
these neurons or that an excess of CNIH-2 compensates for
the loss of CNIH-3. To distinguish between these alternatives,
we generated Cnih2/3fl/fl mice. Deletion of both CNIH-2 and
CNIH-3 resulted in a profound and selective reduction in the
AMPAR-eEPSC, significantly greater than that seen with
CNIH-2 deletion alone (Figures 2C–2F). These results suggest
that CNIH-2 can compensate for the lack of CNIH-3, CNIH-2 is
the dominant of the two isoforms, and CNIH-2 and CNIH-3 are
both essential for synaptic AMPAR expression in the hippo-
campus. Deletion of CNIH-2 and CNIH-3 also reduced mEPSC
amplitude by 20% (Figure 2G), similar to that observed with
CNIH-2 elimination (Figure 2I), whereas mEPSC decay was
faster than elimination of CNIH-2 alone (Figures 2H and 2J). In
Figures 2E, 2F, 2I, and 2J, our CNIH KO results are summarized
and compared to previous results obtained by the conditional
KO of GluA1 (Lu et al., 2009). Strikingly, the effects of CNIH-
2/-3 elimination on the AMPAR-eEPSC, mEPSC amplitude,
and kinetics are indistinguishable from the effects of deleting
GluA1. Interestingly, previous studies on the germline GluA1
KO mouse (Andra´sfalvy et al., 2003; Zamanillo et al., 1999)
did not report a speeding of mEPSCs. We repeated these
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Figure 1. CNIH-2 Deletion Selectively
Reduces Synaptic AMPAR-Mediated Trans-
mission
(A and B) Scatterplots show amplitudes of AMPAR
and NMDAR-eEPSCs for single pairs of neurons
from Cnih2fl/flmice (open circles) and mean ± SEM
(filled circles). The scatterplots represent data ob-
tained from acutemouse slices infected with rAAV-
CRE-GFP at P0 (red circles) and cultured mouse
slices transfected with CRE for 2–3 weeks (black
circles). Distributions show a reduction in AMPAR-
eEPSC amplitude, but no change in NMDAR-
eEPSC amplitude. Insets show sample current
traces from Control (black) and CRE-expressing
(green) cells. Bar graphs show mean ± SEM AM-
PAR and NMDAR-eEPSC amplitudes presented in
scatterplots: (A), control (Ctl), 169.2 ± 24.3 pA;
DCNIH-2, 77.4 ± 10.3 pA (n = 19), *p < 0.001; and
(B), Ctl, 36.5 ± 4.7 pA; DCNIH-2, 32.5 ± 5.9 pA (n =
16), p = 0.3.
(C) Average AMPAR-eEPSC decay kinetics from
pairs of Ctl (black circles) and CRE-infected cells
(green circles) (mean Ctl decay ± SEM, 14.4 ±
1.3 ms; mean DCNIH-2 decay ± SEM, 11.3 ±
1.4 ms; n = 8; *p < 0.01). Inset shows peak-
normalized sample traces.
(D and E) Bar graphs show mean ± SEM mEPSC
amplitude (D, Ctl, 10.0 ± 0.4 pA; n = 8; DCNIH-2,
7.6 ± 0.3 pA; n = 8; *p < 0.01) and decay kinetics (E,
Ctl, 10.0 ± 0.8ms; n = 8;DCNIH-2, 6.4 ± 0.4ms; n =
8; *p < 0.01) of Ctl and CRE-infected neurons from
Cnih2fl/fl mice. Average traces are shown to the
left and are peak-normalized in (E).
(F and G) Bar graphs show mean ± SEM AMPAR
deactivation (F, Ctl, 3.6 ± 0.2 ms; n = 12; DCNIH-2,
2.7 ± 0.2ms; n = 18; *p < 0.002) and desensitization
(G, Ctl, 13.2 ± 0.8 ms; n = 14; DCNIH-2, 8.7 ±
0.4 ms; n = 19; *p < 0.0001) from outside-out
patches pulled from Ctl and CRE-infected cells
and exposed to 1 and 100ms applications of 1 mM
glutamate, respectively. Peak-normalized sample
traces are shown to the left.
(H) Bar graph showsmean ±SEM1mMglutamate-
induced current amplitudes from outside-out
patches pulled fromCtl andCRE-infected cells (Ctl,
870 ± 148 pA; n = 12;DCNIH-2, 458 ± 46 pA; n = 17;
*p < 0.01). Sample traces are shown to the left.
(I) Bar graph shows mean ± SEM IKA/IGlu ratios
from outside-out patches pulled from Ctl and
CRE-infected cells that were exposed to 1 mM
glutamate and 1 mM kainate (Ctl, 0.54 ± 0.03;
n = 5; DCNIH-2, 0.51 ± 0.03; n = 12; p = 0.56).
Sample traces are shown to the left.
See also Figure S2.
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CNIH Proteins Determine AMPAR Subunit Compositionexperiments, however, and observed the same speeding as we
found in the conditional GluA1 KO neurons (Figure S3). We have
no clear explanation for the difference, although Andra´sfalvy
et al. (2003) did report faster deactivation in outside-out patches
from the germline KO mouse. Long-term potentiation (LTP),
which is widely held as the cellular basis for learning and
memory, is also found to be severely reduced in hippocampal
neurons from GluA1 KO mice (Zamanillo et al., 1999). We, there-
fore, examined LTP in neurons lacking CNIH-2/-3. If GluA1-con-
taining AMPARs are removed from synapses in the absenceof CNIH-2/-3, LTP should be compromised. Indeed, when
compared to uninfected neurons, LTP was markedly reduced
in Cnih2/3fl/fl neurons infected with CRE (Figure 2K). Thus,
knocking out CNIH-2/-3 appeared to phenocopy knocking out
GluA1 in three key parameters. Previous studies in HEK cells
(Kato et al., 2010a) suggested that the absence of CNIH proteins
in neurons should result in AMPAR resensitization and alter-
ations in cyclothiazide potentiation of kainate-induced currents.
However, neither of these effects was observed (Figures S3C
and S3D).Neuron 77, 1083–1096, March 20, 2013 ª2013 Elsevier Inc. 1085
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Figure 2. Deletion of CNIH-2/-3 Closely
Resembles GluA1 Elimination
(A and B) Scatterplots show amplitudes of AMPAR
and NMDAR-eEPSCs of Ctl and CRE-transfected
neurons in cultured slices from Cnih3fl/fl mice.
Filled circles show mean ± SEM. Distributions
show no change in AMPAR-eEPSCs or NMDAR-
eEPSCs. Insets show sample current traces. Bar
graphs show mean ± SEM AMPAR and NMDAR-
eEPSC amplitudes presented in scatterplots:
(A), Ctl, 77.0 ± 11.1 pA; DCNIH-3, 83.6 ± 14.2 pA
(n = 10), p = 1; and (B), Ctl, 42.5 ± 5.6 pA;DCNIH-3,
35.7 ± 8.3 pA (n = 10), p = 0.5.
(C and D) Scatterplots showing amplitudes of
AMPAR and NMDAR-eEPSCs of Ctl and CRE-
transfected neurons in cultured slices from Cnih2/
3fl/fl mice. Filled circles show mean ± SEM. Bar
graphs show mean ± SEM amplitudes of AMPAR-
eEPSCs (C, Ctl, 242.5 ± 48.4 pA; DCNIH-2/-3,
52.6 ± 9.4 pA; n = 10; *p < 0.01) and NMDAR-
eEPSCs (D, Ctl, 39.8 ± 5.7 pA; DCNIH-2/-3, 34.1 ±
4.7 pA; n = 10; p = 0.2). Insets show sample current
traces.
(E and F) Bar graphs normalized to Ctl summa-
rizing mean ± SEM eEPSC data from Cnih2fl/fl,
Cnih3fl/fl, and Cnih2/3fl/fl mice compared to
Gria1fl/fl mice. The light-brown bars are published
data from the Gria1fl/fl mouse (Lu et al., 2009).
(G and H) Bar graphs show mean ± SEM mEPSC
amplitude (G, Ctl, 10.0 ± 0.4 pA; n = 8;DCNIH-2/-3,
8.2 ± 0.3 pA; n = 7; *p < 0.01) and decay kinetics
(H, Ctl, 10.0 ± 0.7 ms; n = 8; DCNIH-2/-3, 5.0 ±
0.5 ms; n = 7; *p < 0.001) of Ctl and CRE-infected
neurons from Cnih2/3fl/fl mice. Averaged traces
are shown to the left and are peak-normalized
in (H).
(I and J) Bar graphs normalized to Ctl summarizing
mean ± SEMmEPSC data from Cnih2fl/fl, Cnih3fl/fl,
and Cnih2/3fl/fl mice compared to Gria1fl/fl mice
(Lu et al., 2009).
(K) Mean ± SEM AMPAR-eEPSCs in wild-type
(black) and DCNIH-2/-3 (green) neurons before
and after a whole-cell LTP-pairing protocol
(arrow): Vm = 0 mV, 2 Hz Schaffer collateral stim-
ulation for 90 s normalized to average eEPSC
amplitude prior to LTP induction. LTPwas severely
decreased in DCNIH-2/-3 neurons (Ctl, n = 6;
DCNIH-2/-3, n = 8). Sample traces before and
30–45 min after pairing are shown to the right for
Ctl (black) and DCNIH-2/-3 (green) neurons.
See also Figure S3.
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CNIH Proteins Determine AMPAR Subunit CompositionGluA1 Is Required for the Effect of CNIH-2
Wenext directly testedwhether the effects of deleting CNIH-2/-3
are specifically related to the regulation of GluA1. To this end, we
compared the effects of CNIH-2 knockdown (KD) on AMPAR-
eEPSCs in GluA1 and GluA2 KOmice. The shRNA we generated
was highly effective in knocking downCNIH-2 protein levels (Fig-
ure S4A) and in wild-type neurons produced a phenotype iden-
tical to knocking out CNIH-2 (Figures 1A, 1B, 3A, and 3B). The
KD of CNIH-2 in neurons from GluA2 KO mice, which primarily
express GluA1 homomers, also resulted in a selective but
more pronounced reduction in the AMPAR-eEPSC compared
to wild-type mice (Figures 3C, 3D, 3G, and 3H). In striking
contrast, CNIH-2 KD in slices from GluA1 KO mice had no effect1086 Neuron 77, 1083–1096, March 20, 2013 ª2013 Elsevier Inc.on AMPAR-eEPSCs (Figure 3E), AMPAR mEPSC kinetics
(Figure S4B), or NMDAR eEPSCs (Figure 3F), demonstrating
that CNIH-2 effects on synaptic AMPARs require GluA1. The
eEPSC results are summarized in Figures 3G and 3H. Addition-
ally, residual GluA2A3 receptors in GluA1 KO neurons were
found to have a IKA/IGlu ratio of 0.5, suggesting that all
available TARP binding sites on these receptors are occupied
(Figure S4C).
Although it is well established that CNIH-2 binds to AMPARs
(Kato et al., 2010a; Schwenk et al., 2009; Shi et al., 2010), the rela-
tive binding to GluA subunits has not been reported. Because
CNIH-2 KD has a profound and selective effect on GluA1-con-
taining AMPARs, we compared GluA1 and GluA2 binding to
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Figure 3. GluA1 Is Required for CNIH-2’s
Physical and Functional Interaction with AM-
PARs
(A–F) Scatterplots show amplitudes of AMPAR and
NMDAR-eEPSCs of Ctl and CNIH-2 shRNA-trans-
fected neurons in cultured slices from wild-type,
GluA2 KO, and GluA1 KO mice. Filled circles show
mean ± SEM. Distributions show that the CNIH-2
shRNA reduces the amplitude of AMPAR-eEPSCs in
wild-type (WT) (A, WT, 102.5 ± 16.5 pA; WT + CNIH-
2 shRNA, 52.0 ± 8.6 pA; n = 11; *p < 0.05) and GluA2
KOmice (C, GluA2 KO, 128.9 ± 18.2 pA; GluA2 KO +
CNIH-2 shRNA, 40.2 ± 5.1 pA; n = 10; *p < 0.05), but
not GluA1 KO mice (E, GluA1 KO, 54.8 ± 13.1 pA;
GluA1 KO + CNIH-2 shRNA, 58.1 ± 12.3 pA; n = 9;
p = 0.4). No effects were seen on NMDAR-eEPSCs
(B, WT, 44.3 ± 7.0 pA; WT + CNIH-2 shRNA, 42.0 ±
4.5 pA; n = 10; p = 1; D, GluA2 KO, 39.4 ± 5.1 pA;
GluA2 KO + CNIH-2 shRNA, 34.9 ± 7.4 pA; n = 9; p =
0.4; F, GluA1 KO, 84.9 ± 18.1 pA; GluA1 KO + CNIH-
2 shRNA, 79.5 ± 23.3 pA; n = 8; p = 0.8). Insets show
sample current traces. Bar graphs to the right show
mean ± SEM AMPAR and NMDAR-eEPSC ampli-
tudes presented in scatterplots.
(G and H) Bar graphs normalized to Ctl summarizing
mean ± SEM AMPAR and NMDAR-eEPSC data
from CNIH-2 shRNA transfection of wild-type,
GluA2 KO, and GluA1 KO mice.
(I) Immunoprecipitation (IP) of GluA2, GluA1, and
CNIH-2 from hippocampal lysates of one wild-type
mouse and two GluA1 KO mice using antibodies
against GluA2 and GluA2/3.
See also Figure S4.
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CNIH Proteins Determine AMPAR Subunit CompositionCNIH-2. We first immunoprecipitated GluA2 from wild-type
hippocampal lysates using two different antibodies (anti-GluA2
or anti-GluA2/3). We found that CNIH-2 coimmunoprecipitated
with GluA2 from wild-type hippocampal lysates, as expected
(Figure 3I). In sharp contrast, we observed no coimmunoprecipi-
tation of CNIH-2 with GluA2 when using GluA1 KO lysates.Neuron 77, 1083–109However, CNIH-2 coimmunoprecipitated
with GluA1 from GluA2 KO lysates (Fig-
ure S8B), and g-8 was coimmunoprecipi-
tated with GluA2 from both wild-type and
GluA1 KO lysates (Figure S4D). These
biochemical studies demonstrate a striking
specificity of CNIH-2 binding to GluA1
subunits in the hippocampus. Together,
these data indicate that both the physical
and functional interactions of CNIH-2 with
native AMPARs require the GluA1 subunit.
To evaluate the surface expression
of GluA1 using immunofluorescence
microscopy, we cultured dissociated rat
hippocampal neurons transfected with
CNIH-2 shRNA and visualized somatic
and dendritic surface GluA1 immunoreac-
tivity 20 days later. CNIH-2 shRNA-
transfected neurons were compared to
adjacent untransfected neurons. CNIH-2KD dramatically reduced surface GluA1 (Figures 4A and S5A),
consistent with our findings showing reduction of synaptic
currents. Transfection of a scrambled shRNA or GFP alone had
no effect on surface GluA1 staining (Figures 4B, S5B, and S5C).
Our data, thus far, demonstrate that synaptic expression of
GluA1A2 AMPARs is eliminated in the absence of CNIH-2/-3.6, March 20, 2013 ª2013 Elsevier Inc. 1087
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Figure 4. Residual GluA2A3 Heteromers Can
Account for the Effects of CNIH Elimination
on AMPAR Kinetics
(A and B) Immunolabeling of surface GluA1 in un-
transfected dissociated rat hippocampal neurons
(yellow arrows) compared to neurons transfected
with either CNIH-2 shRNA (A) or a scrambled
shRNA (B) (white arrows). Somatic dark regions
are by-products of the confocal image thickness.
Dendritic regions of transfected (1) and un-
transfected (2) neurons are shown at a higher
magnification below.
(C) Peak-normalized sample traces showing
AMPAR deactivation in outside-out patches from
HEK cells transfected with GluA1A2 and g-8 or
GluA2A3 and g-8.
(D) Bar graph showing mean ± SEM deactivation of
GluA1A2g-8 and GluA2A3g-8 complexes and the
change in AMPAR deactivation kinetics in outside-
out patches from DCNIH-2 and DCNIH-2/-3 CA1
pyramidal neurons: GluA1A2 + g-8, 3.9 ± 0.4 ms
(n = 10); GluA2A3 + g-8, 1.8 ± 0.2 ms (n = 10), p <
0.001; wild-type, 3.6 ± 0.2 ms (n = 12); DCNIH-2,
2.7 ± 0.2 ms (n = 18), *p < 0.002; and DCNIH-2/-3,
1.6 ± 0.2 ms (n = 6), *p < 0.0001.
(E) Bar graph showing mean ± SEM deactivation of
GluA2A3g-8 complexes normalized to GluA1A2g-8
complexes in outside-out patches from HEK cells
(Glu) compared to the percent change in mEPSC
decay (mEPSC) in DCNIH-2/-3 and DGluA1 CA1
pyramidal neurons (*p < 0.001).
See also Figure S5.
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CNIH Proteins Determine AMPAR Subunit CompositionWhat then accounts for the fast kinetics of the remaining
AMPARs observed after deleting CNIH-2/-3? Importantly, dele-
tion of GluA1 results in the same fast kinetics, suggesting that1088 Neuron 77, 1083–1096, March 20, 2013 ª2013 Elsevier Inc.the kinetics are a direct result of the
specific molecular composition of the re-
maining receptors, which are primarily
GluA2A3g-8 complexes (Lu et al., 2009).
Therefore, we next used heterologous
cells to evaluate whether CNIH-2 affects
AMPAR kinetics by specifically regulating
GluA1A2 trafficking. We coexpressed
GluA2, GluA3, and g-8 in HEK cells and
measured the deactivation of this recep-
tor complex (Figures 4C–4E). For all
experiments, flip-type AMPAR sub-
units were evaluated (see Supplemental
Experimental Procedures). GluA2A3g-8
complex deactivation is twice as fast as
GluA1A2g-8, with GluA2A3g-8 deactiva-
tion being virtually identical to the deacti-
vation of AMPARs in CRE-expressing
Cnih2/3fl/fl neurons (Figure 4D). Further-
more, the difference in deactivation
between GluA1A2g-8 and GluA2A3g-8
complexes is virtually identical to the
magnitude of change in mEPSC decay in
both CRE-expressing conditional GluA1and CNIH-2/-3 (Gria1fl/fl and Cnih2/3fl/fl) KO neurons (Figure 4E).
Thus, these findings indicate that the kinetic changes caused by
the deletion of CNIH-2/-3 in neurons can be fully explained by the
Neuron
CNIH Proteins Determine AMPAR Subunit Compositionselective removal of the GluA1 subunit, leaving GluA2A3g-8
complexes with faster kinetics.
Effect of CNIH-2 Deletion on Synaptic Proteins
The lack of synaptic GluA1-containing AMPARs in the absence
of CNIH-2/-3 expression may be explained by either a selective
loss in total GluA1 protein expression or a specific involvement of
CNIH proteins in the forward trafficking of GluA1-containing
AMPARs to synapses. To examine potential effects of CNIH-2
on synaptic protein expression, Cnih2fl/fl mice were crossed
to the Nex-CRE mouse line to create NexCnih2/ mice. CRE
expression in these mice includes pyramidal neurons of the
neocortex and hippocampus as well as mossy and granule cells
in the dentate gyrus (Goebbels et al., 2006).
We first used AMPA/NMDA ratios to ensure that similar
synaptic defects were present in the hippocampus of
NexCnih2/ mice. Because CNIH-2 has no effect on NMDAR-
eEPSCs, a change in this ratio should be an accurate reflection
of synaptic AMPAR content. AMPA/NMDA ratios were reduced
by half in CA1 pyramidal neurons lacking CNIH-2 (Figure 5A).
We also observed similar reductions in dentate granule neurons
and layer 2/3 pyramidal neurons in barrel cortex (Figure 5A).
Interestingly, no change in the ratio was found in the heterozy-
gous (NexCnih2+/) mice (Figure 5A) despite a 30%–50% reduc-
tion in total CNIH-2 expression (Figure S6A), thus providing
further evidence that CNIH-2 is expressed in excess in CA1 pyra-
midal neurons and that all available CNIH-2 binding sites on
AMPARs are occupied or ‘‘saturated.’’ In paired recordings
from slice cultures from NexCnih2/ mice, transfection of CA1
pyramidal neurons with CNIH-2 fully rescued AMPAR-eEPSCs
(Figure 5B). No change in the NMDAR-eEPSC was observed
(Figure 5C). As previously shown, CNIH-2 overexpression in
wild-type neurons has no effect on AMPAR- or NMDAR-eEPSCs
(Figures S6B and S6C) (Shi et al., 2010), again indicating satura-
tion of CNIH binding sites on native AMPARs.
We next examined the total expression level of a number of
synaptic proteins in NexCnih2/ mice. Importantly, no CNIH-2
protein was detected in hippocampal lysates, confirming that
CNIH-2 is absent in the hippocampus of these mice (Figures
5D and 5E). We found that GluA1 and GluA2 were reduced by
about 15%, but no change was observed for g-8, PSD-95, or
the NMDAR subunit GluN2A (Figure 5D). Infection of dissociated
hippocampal neurons with the CNIH-2 shRNA also produced
little effect on total GluA1 and GluA2 expression levels (Fig-
ure S4A). We then compared the consequences of deleting
CNIH-2 to g-8 deletion (Figure 5E). Total expression of GluA1
and GluA2 is more severely reduced in g-8 KO mice than in
NexCnih2/ mice, and unlike the lack of change in g-8 levels
in NexCnih2/ mice, total CNIH-2 expression is markedly
reduced in g-8 KO mice, as reported previously by Kato et al.
(2010a).
Because the modest loss of AMPAR protein in the absence of
CNIH-2 expression is unlikely to explain the profound effects on
physiology, we next examined the effect of deleting CNIH-2 on
AMPAR trafficking to the cell surface. AMPARs are glycopro-
teins, which traffic through the biosynthetic pathway. To deter-
mine whether CNIH-2 affects AMPAR maturation, we examined
receptor glycosylation using endoglycosidase H (Endo H), whichdigests immature high-mannose sugars, and PNGase F, which
removes allN-linked carbohydrates. Relative to wild-type brains,
both GluA1 and GluA2 showed increased sensitivity to Endo H
in NexCnih2/ brains (Figures 5F and S6D), as demonstrated
by stronger Endo H-sensitive immature bands (red arrows)
compared to Endo H-resistant mature bands (blue arrows).
These data suggest that a large pool of immature receptors is re-
tained in the ER or cis-Golgi in the absence of CNIH-2. The Endo
H-sensitive band comigrates with completely deglycosylated
receptors following treatment with PNGase F.
We also reexamined the distribution of CNIH-2 protein in the
hippocampus, using an antibody we recently generated using
the same epitope as Kato et al. (2010a). As in our previous study
(Shi et al., 2010), the large majority of CNIH-2 was intracellular.
However, with this alternative antibody, CNIH-2 could also be
detected on the cell surface (Figure 5G).
TARP g-8 Reverses the CNIH-2-Induced Slowing of
GluA2-Containing AMPARs, but Not Homomeric GluA1
Receptors
In heterologous cells, CNIH-2 hasmarked effects on GluA1-con-
taining and -lacking AMPARs (Schwenk et al., 2009). What then
accounts for the selective effects of CNIH-2 deletion on native
GluA1-containing receptors? Furthermore, how can one recon-
cile the fact that all CNIH binding sites appear to be occupied
in CA1 neurons, and yet endogenous AMPAR kinetics are
considerably faster than the kinetics of AMPARs coexpressed
with CNIH-2 in expression systems? To better understand the
AMPAR kinetics in expression systems, we examined a variety
of conditions. Initially, we measured the effects of CNIH-2 and
g-8, the primary TARP in the hippocampus (Rouach et al.,
2005), on receptors of defined subunit composition in HEK cells.
As seen previously, CNIH-2 significantly slowed deactivation of
GluA1 homomeric receptors and to a greater extent than g-8
(Figure 6Ai). Expression of both CNIH-2 and g-8 did not signifi-
cantly change the slowing seen with CNIH-2 alone (Figure 6Ai).
These findings could be explained by CNIH-2 and g-8 binding
to the same site on GluA1 subunits with CNIH-2 displacing g-8 or
the two proteins binding to separate sites. The fact that the slow-
ing of kinetics seen with CNIH-2 is the same in GluA1-containing
AMPARs with covalently attached g-8 (Shi et al., 2010) suggests
that CNIH-2 is not displacing g-8. Furthermore, the fact that the
IKA/IGlu ratio, a sensitivemeasure of g-8/AMPAR stoichiometry, is
unchanged (Figure 6Aii) also strongly argues that CNIH-2 is not
displacing g-8 and that g-8 and CNIH-2 are able to co-occupy
GluA1 subunits. These results, however, do not explain why
CNIH-2 appears to occupy all available binding sites on neuronal
AMPARs, and yet native neuronal AMPAR kinetics are substan-
tially faster than what is observed when CNIH-2 and g-8 are ex-
pressed with homomeric GluA1. Might GluA2 behave differently
from GluA1, in that essentially all native AMPARs in CA1 pyra-
midal neurons contain the GluA2 subunit (Lu et al., 2009)? We
therefore examined the effect of CNIH-2 on GluA2 homomers
in HEK cells. Unedited GluA2(Q) was used owing to its ability
to form functional channels at higher levels than GluA2(R). Like
GluA1, we found that CNIH-2 slowed deactivation of GluA2
homomers (Figures 6B). However, in sharp contrast to GluA1,
the coexpression of g-8 reversed the slowing of homomericNeuron 77, 1083–1096, March 20, 2013 ª2013 Elsevier Inc. 1089
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Figure 5. CNIH-2 Deletion Impedes AMPAR
Trafficking with Little Effect on Other
Synaptic Proteins
(A) Bar graphs show mean ± SEM AMPA/NMDA
ratios of primary neurons in CA1, dentate
gyrus, and barrel cortex from wild-type (WT),
NexCnih2+/, and NexCnih2/ mice: CA1, WT,
3.6 ± 0.5 (n = 8); NexCnih2+/, 3.7 ± 0.5 (n = 5);
NexCnih2/, 1.8 ± 0.2 (n = 8), *p < 0.001; DG,WT,
3.6 ± 0.3 (n = 8); NexCnih2/, 1.7 ± 0.2 (n = 8); and
BC, WT, 2.9 ± 0.5 (n = 5); NexCnih2/, 1.6 ± 0.2
(n = 6), *p < 0.05. AMPA and NMDA sample
current traces from CA1 of wild-type and
NexCnih2/ mice normalized to NMDAR current
at 150 ms are shown to the left.
(B and C) Scatterplots showing that transfection
of NexCnih2/ neurons with CNIH-2 restores the
AMPAR-eEPSC amplitude to wild-type levels.
Filled circles showmean ± SEM. Bar graphs to the
right of scatterplots show corresponding mean ±
SEM eEPSC amplitudes: (B), NexCnih2/, 53.3 ±
16.9 pA; NexCnih2/ + CNIH-2, 109.1 ± 29.6 pA
(n = 7), *p < 0.05; and (C), NexCnih2/, 60.2 ±
8.7 pA; NexCnih2/ + CNIH-2, 55.5 ± 7.7 pA
(n = 7), p = 0.8. Insets show corresponding sample
traces.
(D) Immunoblots from hippocampal lysates of
wild-type and NexCnih2/ mice comparing ex-
pression levels of synaptic proteins. Bar graph
to the right shows average synaptic protein
levels ± SEM in NexCnih2/ mice normalized to
wild-type mice: CNIH-2, 0.04 ± 0.008; GluA1,
0.84 ± 0.033; GluA2, 0.82 ± 0.057; g-8, 0.97 ±
0.062; PSD-95, 0.97 ± 0.039; NR2A, 1.01 ± 0.081
(n = 3–5), *p < 0.05.
(E) Immunoblots from hippocampal lysates of
wild-type, NexCnih2/ and g-8 KO mice com-
paring total GluA1, GluA2, g-8, and CNIH-2
expression levels. Bar graph to the right shows
average GluA1, GluA2, g-8, and CNIH-2 expres-
sion levels ± SEM in NexCnih2/ and g-8 KO
mice normalized to wild-type mice: NexCnih2/
mice, GluA1, 0.83 ± 0.03; GluA2, 0.89 ± 0.02; g-8,
0.99 ± 0.05; CNIH-2, 0.05 ± 0.02 (n = 3); and g-8
KO mice, GluA1, 0.49 ± 0.05; GluA2, 0.50 ± 0.04;
g-8, 0.03 ± 0.01; CNIH-2, 0.28 ± 0.02 (n = 3),
*p < 0.05.
(F) Glycosylation analysis of GluA1 and GluA2 in
wild-type and NexCnih2/ mice. The represen-
tative blot to the left shows the relative amount of
mature GluA1 receptor subunits (blue arrows) to
immature GluA1 subunits (red arrows) in hippocampal lysates from wild-type and NexCnih2/ mice. Bar graph to the right shows the average ratio ± SEM of
immature to mature GluA1 and GluA2 subunits in NexCnih2/mice normalized to wild-type mice: GluA1, 1.99 ± 0.28; and GluA2, 1.70 ± 0.13 (n = 3–5), *p < 0.05.
(G) Biotinylation analysis of GluA1, GluA2, g-8, and CNIH-2 in dissociated hippocampal neurons.
See also Figure S6.
Neuron
CNIH Proteins Determine AMPAR Subunit CompositionGluA2 kinetics caused by CNIH-2 (Figure 6B). The IKA/IGlu ratio of
GluA2(Q) in the presence of both g-8 and CNIH-2 was 0.48 ±
0.04 (n = 6), indicating a four g-8 receptor (Figure S7). We
repeated the experiments with GluA1A2(R) heteromers, the
subunit composition that accounts for the majority of endoge-
nous AMPARs in CA1 neurons (Lu et al., 2009). When GluA1A2
heteromers were coexpressed with either g-8 or CNIH-2,
CNIH-2 produced a much stronger slowing of deactivation1090 Neuron 77, 1083–1096, March 20, 2013 ª2013 Elsevier Inc.compared to g-8, as expected. Remarkably, however, coex-
pression of g-8 and CNIH-2 with GluA1A2 heteromers reversed
CNIH-2-induced slowing (Figure 6C). Together, these findings
are of considerable interest for two main reasons. One, such
data are consistent with a model in which g-8 prevents the phys-
ical interaction of CNIHwith non-GluA1 subunits, thus explaining
the observed CNIH subunit specificity. And two, when CNIH-2 is
bound to GluA1 but prevented from functionally interacting with
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Figure 6. g-8 Blocks CNIH-2’s Functional Interaction with GluA2, but Not GluA1
(A) Bar graph shows mean ± SEM deactivation kinetics of GluA1 homomers expressed in HEK cells alone, with g-8, with CNIH-2, and with g-8 and CNIH-2: (Ai),
GluA1, 1.8 ± 0.2ms (n = 10); GluA1 + g-8, 4.9 ± 0.3ms (n = 8); GluA1 +CNIH-2, 8.7 ± 0.6ms (n = 11); and GluA1 + g-8 + CNIH-2, 9.4 ± 0.7ms (n = 12). Mean ± SEM
IKA/IGlu ratios for GluA1 + g-8 and GluA1 + g-8 + CNIH-2 were also compared: (Aii), GluA1 + g-8, 0.57 ± 0.03 (n = 8); and GluA1 + g-8 + CNIH-2, 0.54 ± 0.05 (n = 5).
(B and C) Bar graphs show mean ± SEM deactivation kinetics of GluA2(Q) homomers and GluA1A2(R) heteromers expressed in HEK cells alone, with g-8, with
CNIH-2, and with g-8 and CNIH-2: (B), GluA2(Q), 1.2 ± 0.2ms (n = 8); GluA2(Q) + g-8, 4.5 ± 1.0ms (n = 4); GluA2(Q) + CNIH-2, 10.0 ± 1.5ms (n = 7); andGluA2(Q) +
g-8 + CNIH-2, 6.0 ± 0.7 ms (n = 6); and (C), GluA1A2(R), 1.7 ± 0.4 ms (n = 6); GluA1A2(R) + g-8, 3.9 ± 0.4 ms (n = 10); GluA1A2(R) + CNIH-2, 11.7 ± 1.0 ms (n = 6);
and GluA1A2(R) + g-8 + CNIH-2, 5.7 ± 0.5 ms (n = 9), *p < 0.05. Corresponding peak-normalized sample traces are shown to the left of bar graphs.
See also Figure S7.
Neuron
CNIH Proteins Determine AMPAR Subunit CompositionGluA2 by g-8, as would be expected in neurons, CNIH-2 has little
influence on the kinetics of GluA1A2 heteromers. It is important
to note that previous efforts to understand CNIH function have
focused heavily on whether or not CNIH proteins are associated
with synaptic AMPARs or sequestered in the ER. The present
data appear to diminish the relevance of this issue owing to
the fact that all of the physiological consequences of deleting
CNIH proteins can be explained by the selective loss of synaptic
GluA1A2 heteromers.
Based on the results in Figure 6Ai, one might expect the
kinetics of the AMPAR EPSC to be slow in pyramidal neurons
from GluA2 KO mice, because most receptors are composed
of GluA1 homomers (Lu et al., 2009), presumably bound to
CNIH-2/-3. This, however, is not the case (Lu et al., 2009).
Surprisingly, we find a marked enhancement in the total expres-
sion and association of g-2 with GluA1-containing receptors
when GluA2 expression is reduced (Figures S8A and S8B). g-2
has been shown to reverse the kinetic effects of CNIH-2/-3 on
GluA1 homomers (Gill et al., 2012; Figure S8C). Indeed, in
neurons from stargazer mice (a g-2-deficient mouse line),
GluA2 KD leads to slowing of AMPA mEPSC decay kinetics as
expected (Figures S8D and S8E). See Figure S8 for more details.
CNIH-2 Enhances AMPAR-Mediated Responses in the
g-8 KO
The aforementioned results provide an explanation for the
paradox that, whereas all CNIH-2 binding sites of native
AMPARs seem to be occupied, the kinetics of neuronal AMPARs
are fast. That is, under normal conditions, g-8 prevents a func-
tional association of CNIH-2/-3 to GluA2 and thus prevents the
expected slowing of GluA1A2 heteromers. If thismodel is correct
and CNIH proteins are able to associate with AMPARs on the
surface, then deleting g-8 should cause a marked slowing in
mEPSCs. However, whereas we confirmed a reduction in
mEPSC amplitude in g-8 KO mice (Figure 7A), no effect onmEPSC decay was observed (Figure 7B) (Rouach et al., 2005).
One explanation for this might be that CNIH-2 is expressed at
severely reduced levels in g-8 KO mice (Figure 5E) (Kato et al.,
2010a). Therefore, we expressed CNIH-2 in slice cultures
made from g-8 KOmice and found that CNIH-2 not only rescued
the amplitude of the AMPAR-mEPSCs (Figure 7A) but also mark-
edly slowed mEPSC responses, such that the kinetics were
considerably slower than what is seen in wild-type neurons or
when CNIH-2 is overexpressed in wild-type neurons (Figure 7B).
These data are compelling for several reasons. One, they show
that CNIH-2 effects on AMPAR kinetics are similar in HEK cells
and in neurons lacking g-8. Two, they emphasize the critical
role that g-8 has in determining the effects of CNIH-2/-3 on
AMPAR kinetics. And three, they demonstrate that CNIH pro-
teins are able to associate with synaptic AMPARs. Although
we maintain that the primary role for CNIH proteins is in the
selective trafficking of GluA1A2 heteromers to synapses, the
presence of CNIH protein on the surface of neurons (Figure 5G)
and the ability of CNIH-2 to influence gating properties of
synaptic AMPARs in the absence of g-8 (Figure 7B) are consis-
tent with a selective and likely inert association of CNIH protein
with GluA1 subunits of native synaptic GluA1A2 heteromers in
the presence of g-8.
DISCUSSION
In this study, we used a variety of approaches, including the
generation of conditional KO mice for CNIH-2 and CNIH-3, to
determine the role of cornichon proteins in the regulation of
neuronal AMPARs. By deleting CNIHs from neurons, we reveal
a critical role for these proteins in regulating AMPAR-mediated
synaptic transmission because there is a profound loss of
AMPAR currents in KO neurons. We have demonstrated that
under native conditions, CNIH is saturating, and the KD or
KO of CNIHs is essential for studying their roles in neurons.Neuron 77, 1083–1096, March 20, 2013 ª2013 Elsevier Inc. 1091
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Figure 7. CNIH-2 Slows Synaptic AMPAR Currents in the Absence
of g-8
(A and B) Bar graphs showmean ± SEMmEPSC amplitude (A) and decay (B) of
wild-type, NexCnih2/, CNIH-2-overexpressing (OE), g-8 KO, and g-8 KO +
CNIH-2 CA1 pyramidal neurons in cultured hippocampal slices: (A), wild-type,
17.4 ± 1.6 pA (n = 8); NexCnih2/, 9.5 ± 0.5 pA (n = 9); CNIH-2 OE, 17.3 ±
1.6 pA (n = 5); g-8 KO, 10.7 ± 0.9 pA (n = 9); and g-8 KO +CNIH-2, 19.1 ± 3.5 pA
(n = 7), *p < 0.05; and (B), wild-type, 6.3 ± 0.4 ms (n = 8); NexCnih2/, 4.4 ±
0.3 ms (n = 9); CNIH-2 OE, 6.4 ± 0.4ms (n = 5); g-8 KO, 7.8 ± 0.6ms (n = 9); and
g-8 KO + CNIH-2, 14.2 ± 0.63 ms (n = 7), *p < 0.05. Select color-matched
sample traces are shown above the bar graphs. Sample traces in (B) are peak-
normalized. Note that compared to acute slices, baseline mEPSC amplitude is
larger, and mEPSC kinetics are faster in slice culture (see Supplemental
Experimental Procedures).
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CNIH Proteins Determine AMPAR Subunit CompositionFurthermore, we find an unanticipated subunit specificity, in that
CNIH-2/-3 preferentially interact with and functionally regulate
GluA1-containing AMPARs. Strikingly, CNIH-2/-3 KO neurons
phenocopy GluA1 KO neurons with respect to their current
amplitudes, kinetics, and synaptic plasticity. All of our findings
are most consistent with a model in which the primary role of
CNIH-2/-3 in CA1 pyramidal neurons is the selective trafficking
of GluA1-containing receptors to synapses.
A Model for the Interaction between g-8 and CNIH with
AMPAR Subunits
Figure 8 summarizes the proposed interactions between g-8 and
CNIH with surface AMPAR subunits. This model is based
primarily on data in which g-8 and CNIH are expressed with
the various AMPAR subunits in HEK cells but, as we discuss
below, is strongly supported by our data from CA1 pyramidal
neurons. We propose based on the IKA/IGlu ratio, a sensitive
assay for TARP stoichiometry (Shi et al., 2009), that all AMPAR
subunit combinations presented in Figure 8 contain four g-8
as shown in HEK cells for AMPAR homomers (Figures 6Aii
and S7) and in neurons for AMPAR heteromers (Figures 1I
and S4C). The rest of this discussion concerns the number of
CNIH proteins associated with the various AMPAR subunit
combinations.1092 Neuron 77, 1083–1096, March 20, 2013 ª2013 Elsevier Inc.GluA1 Homomers
The deactivation of GluA1 homomers in the presence of both g-8
and CNIH in HEK cells is at least as slow as that observed with
CNIH alone (Figure 6Ai). Furthermore, the IKA/IGlu ratio of GluA1
homomers is the same when expressed in HEK cells with only
g-8 and when CNIH-2 and g-8 are coexpressed (Figure 6Aii).
Therefore, these receptors must be associated with at least
one and possibly four CNIH molecules, in addition to the four
g-8 (Figure 8A). We cannot be more precise on the CNIH stoichi-
ometry, but g-8 and CNIH-2 are capable of co-occupying GluA1
subunits.
GluA2 Homomers
In HEK cells, based on the same fast kinetics of GluA2 homo-
mers in the presence of both g-8 and CNIH or with g-8 alone
(Figure 6B), we propose that g-8 prevents GluA2 subunits from
associating with CNIH, with GluA2 homomers containing four
g-8 and zero CNIH (Figure 8B). This model is supported by the
ability of hippocampal GluA2A3 receptors to coimmunoprecipi-
tate with g-8 but not CNIH-2 (Figures 3I and S4D).
GluA1A2 Heteromers
The fast kinetics seen with this heteromer in the presence of g-8
and CNIH in HEK cells indicate that CNIH has little effect, sug-
gesting the absence of CNIH on this heteromer on the surface
(Figure 6C). Alternatively, because CNIH does interact with
surface GluA1 homomers in the presence of g-8 (Figure 6A),
CNIH could be associated with GluA1 subunits of surface
GluA1A2 heteromers but not affect the kinetics of these hetero-
mers.Wild-type AMPARs in CA1 pyramidal neurons are primarily
GluA1A2 (Lu et al., 2009) and exhibit deactivation kinetics char-
acteristic of limited CNIH influence on GluA1A2-gating kinetics
(Figures 4D and 6C). In the hippocampus, our biochemical
data show that CNIH-2 associates exclusively with GluA1A2
receptors through the GluA1 subunit (Figures 3I and S8B), and
we do observe CNIH-2 on the surface of hippocampal neurons
(Figure 5G). Because of such data, we would argue that native
surface GluA1A2 receptors could have up to two CNIHs associ-
ated with the GluA1 subunits but that, if present, they exert no
effect on gating kinetics due to g-8’s prevention of a functional
CNIH association with the GluA2 subunit (Figure 8C). If this is
the case, CNIH expression in the absence of g-8 should slow
the gating kinetics of surface AMPARs in neurons. Indeed,
when CNIH-2 is expressed in pyramidal neurons from g-8 KO
mice, the gating kinetics of surface AMPARs at synapses are
markedly slowed (Figure 7B).
GluA2A3 Heteromers
In GluA1 KO mice, the remaining GluA2A3 receptors bind to g-8
and have a high IKA/IGlu ratio, indicating that they also contain
four g-8 (Figures S4C and S4D). The fast kinetics of native
neuronal GluA2A3 receptors in GluA1 conditional KO mice (Fig-
ure 4E), the inability of CNIH-2 KD to influence AMPA EPSCs of
neurons from GluA1 KO mice (Figures 3E and S4B), and the
failure of neuronal GluA2A3 receptors to coimmunoprecipitate
CNIH-2 (Figure 3I) argue that CNIH is prevented from associating
with these receptors. Thus, we assert that GluA2A3 receptors
contain four g-8 and zero CNIH molecules (Figure 8D). Although
speculative, given the likelihood that g-8 inhibits the interaction
of CNIH on GluA2 subunits, we believe that g-8 may similarly
inhibit CNIH interaction with GluA3.
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Figure 8. Model of CNIH and g-8 Interac-
tions with AMPARs
(A) GluA1 AMPAR subunits simultaneously asso-
ciate with CNIH proteins and TARP g-8. Therefore,
we propose that surface tetrameric GluA1 homo-
mers associate with four g-8 molecules and one to
four CNIH molecules.
(B) CNIH protein association with GluA2 AMPAR
subunits appears to be prevented by g-8. There-
fore, in the presence of g-8, we propose that
surface GluA2 homomers associate with four g-8
molecules and zero CNIH molecules.
(C) Because of GluA1 and GluA2’s respective
relationships with g-8 and CNIH proteins, we
propose that surface GluA1A2 heteromers asso-
ciate with four g-8 molecules and one to two
CNIH molecules.
(D) Because GluA1 is required for the physical
association of CNIH proteins but not g-8 with
AMPARs in neurons, we propose that surface GluA2/3 heteromers associate with four g-8 molecules and zero CNIH molecules.
(E) In neurons, CNIH proteins selectively promote the trafficking of GluA1A2 heteromers but not GluA2A3 heteromers to the neuronal surface. g-8 prevents CNIH
interaction with non-GluA1 subunits and provides a mechanism for the subunit-specific action of CNIH on GluA1A2 receptor trafficking. Overexpression of CNIH
in wild-type neurons does not slow AMPAR-gating kinetics, indicating that CNIH cannot displace g-8 on non-GluA1 subunits. Together, these data suggest
a model whereby in the ER/Golgi, g-8 associates with AMPARs prior to CNIH (1), thus limiting subsequent CNIH interactions to only GluA1 subunits, which
uniquely associate with both g-8 and CNIH (2). CNIH proteins would then selectively enable the forward trafficking of GluA1A2 heteromers to the neuronal
surface (3). CNIH deletion prevents GluA1A2 receptors from leaving the ER/Golgi.
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CNIH Proteins Determine AMPAR Subunit CompositionCNIH-2/-3 Selectively Interact with GluA1 Subunits and
Are Required for Synaptic Expression of GluA1-
Containing AMPARs in CA1 Pyramidal Neurons
Previous studies, including our own, report little effect of CNIH
overexpression on endogenous AMPARs. However, CNIHs
clearly interact with AMPARs in heterologous cells and in
neurons (Harmel et al., 2012; Shi et al., 2009; Schwenk et al.,
2009; Kato et al., 2010a; Gill et al., 2011, 2012). To test whether
CNIHs have an important role in neurons but are expressed
at saturating levels, we performed extensive analyses using
genetic deletion and KD of CNIHs. Indeed, we found that dele-
tion of CNIH-2/-3 causes a profound and selective reduction in
AMPAR-eEPSC amplitude. This is accompanied by faster decay
of mEPSCs, faster deactivation and desensitization of gluta-
mate-evoked currents from somatic patches, and compromised
LTP induction. These results demonstrate a critical role for
CNIHs in neuronal AMPAR regulation and are particularly fasci-
nating given that the profound synaptic changes seen with the
deletion of CNIH-2/-3 match those seen with the selective dele-
tion of GluA1 (Lu et al., 2009). Because neurons lacking CNIH
proteins look physiologically similar to neurons lacking GluA1,
we hypothesized that removal of CNIH-2/-3 might have different
effects in various AMPAR KO mice and therefore used these
tools to probe CNIH-2 function. Knocking down CNIH-2 in
hippocampal slices from GluA2 KO mice causes a profound re-
duction of AMPAR-eEPSCs, whereas knocking down CNIH-2
in slices from GluA1 KO mice has no effect, either on the ampli-
tude or kinetics of AMPAR EPSCs. These physiological results
support a selective action of CNIH-2/-3 on GluA1-containing
receptors. We also found that CNIH-2 and GluA1 coimmunopre-
cipitate with GluA2 when using wild-type hippocampal homoge-
nates. However, in striking contrast, when using homogenates
from GluA1 KO mice, CNIH-2 does not coimmunoprecipitate
with GluA2. Furthermore, GluA2A3/g-8 receptors, themost likelycomposition of the receptors remaining in neurons lacking GluA1
or CNIH-2/-3, are twice as fast as GluA1A2/g-8 receptors. Thus,
the 50% reduction in mEPSC decay observed in neurons lacking
GluA1 and CNIH-2/-3 can be explained by the selective loss of
synaptic GluA1-containing AMPARs.
g-8 Prevents the Action of CNIH-2/-3 on Non-GluA1
Subunits
Why is the action of CNIH-2/-3 confined to the GluA1 subunit?
Previous studies in heterologous systems have shown that
CNIH-2 has significant effects on AMPARs containing and lack-
ing GluA1 subunits (Schwenk et al., 2009). To address this
seeming contradiction, we examined the interactions between
CNIH-2 and g-8, the most prevalent TARP in the hippocampus
(Rouach et al., 2005), on the kinetics of AMPARs of defined
subunit composition. Remarkably, whereas g-8 was incapable
of reversing the slowing caused by CNIH-2 on homomeric
GluA1 receptors, it fully reversed the slowing caused by
CNIH-2 on homomeric GluA2 receptors, revealing exquisite
selectivity of CNIH-2 for GluA1 over GluA2 due to g-8 preventing
a functional association of CNIH-2 with GluA2.
The marked slowing of deactivation is one of the most prom-
inent effects of CNIH-2 on heterologously expressed AMPARs.
Does CNIH-2 make any contribution to the kinetics of AMPARs
in CA1 pyramidal neurons? As discussed above, the speeding
of AMPAR kinetics in neurons lacking CNIH-2/-3 can be fully
accounted for by the selective loss of GluA1-containing recep-
tors without any need for a direct action of CNIH-2 on the gating
of surface/synaptic AMPARs, raising the question as to whether
CNIH-2 is, in fact, associated with surface/synaptic AMPARs.
Results from other groups (Gill et al., 2011; Kato et al., 2010a),
based largely on data from heterologous cells, found that
CNIH proteins prevent AMPAR resensitization, suggesting that
the lack of resensitization in neurons is due to the presence ofNeuron 77, 1083–1096, March 20, 2013 ª2013 Elsevier Inc. 1093
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CNIH Proteins Determine AMPAR Subunit CompositionCNIH proteins. However, we failed to see resensitization in
neurons lacking CNIH proteins (Figure S3C). We also found
that g-8 reverses the effects of CNIH-2 on the deactivation of
GluA1A2 heteromers. Taken together, these findings may leave
very little room for a physiologically relevant role for CNIH
proteins on synaptic AMPAR gating in neurons and perhaps
diminish the relevance of arguments concerning the presence
of CNIH proteins on surface AMPARs. However, we do detect
the expression of endogenous CNIH on the surface of neurons
and are able to observe effects of CNIH-2 on synaptic AMPAR
gating in the absence of g-8. Therefore, it is possible for CNIH
proteins to associate with synaptic AMPARs. As stated above,
such data point to a selective and potentially inert association
of CNIH proteins with GluA1 subunits of synaptic GluA1A2 het-
eromers, with g-8 bound to all four subunits, as previously
proposed (Shi et al., 2009).
CNIH-2/-3 Promote Forward Trafficking of GluA1-
Containing AMPARs in the ER/Golgi
How do CNIH-2/-3 control the level of AMPARs on the surface of
hippocampal pyramidal neurons? One possibility is that in the
absence of CNIH-2/-3, AMPAR protein is lost, similar to what
is seen in g-8 KO mice (Rouach et al., 2005). However, the
modest loss of AMPAR protein seen in the NexCnih2/ mice
cannot explain the profound loss of surface AMPARs. Rather,
our data suggest that the maturation of AMPARs is impaired
and that the immature receptors are retained in the ER/cis-Golgi.
As pointed out previously (Shi et al., 2009), such a role is remark-
ably similar to the established role of the yeast (Erv14p) and
Drosophila (Cni) CNIH homologs, in which these proteins serve
as chaperones that aid in the forward trafficking of EGFR ligands
from the ER to Golgi (Bo¨kel et al., 2006; Castillon et al., 2009;
Roth et al., 1995). However, unlike the yeast and Drosophila
homologs, but analogous to its effects in HEK cells, CNIH-2
can remain associated with neuronal AMPARs, at least in the
absence of g-8 protein.
More specifically, our results indicate that CNIH is essential for
the functional expression of GluA1-containing receptors on the
surface. Although, at present, we cannot say at what forward
trafficking step of these receptors requires CNIH proteins. It is
possible that CNIH proteins are required for the transport of
GluA1-containing AMPARs from the ER to the Golgi, from the
Golgi to the neuronal surface, or both. Future study will undoubt-
edly be necessary to answer these questions. However, our data
would suggest that g-8 proteins associate with AMPARs prior to
CNIH proteins as AMPARs progress through the secretory
pathway due to g-8 seemingly being required for the subunit-
specific actions of CNIH proteins on the surface trafficking of
GluA1A2 heteromers (Figure 8E).
Our results raise two related issues. First, the delivery of the
GluA1 subunit to the surface of CA1 pyramidal neurons requires
CNIHs. Yet, this is clearly not the case in heterologous expres-
sion systems. What accounts for the difference? The situation
may be analogous to TARP g-2, which is essential for the surface
delivery of AMPARs in CGNs and greatly facilitates surface
delivery of AMPARs in heterologous cells but is not essential
for their delivery. Second, can the results obtained in CA1 pyra-
midal neurons be applied to other neurons? Our results suggest1094 Neuron 77, 1083–1096, March 20, 2013 ª2013 Elsevier Inc.that CNIH-2 plays a similar role in AMPAR trafficking in both
dentate granule neurons and layer 2/3 neocortical neurons.
However, these neurons are likely to be similar to CA1 neurons
in their expression of GluA1A2 heteromers and TARP g-8. Is
there an example of a neuron that expresses GluA1 subunits,
but not CNIH-2? Our results would suggest not because the
surface expression of GluA1 in neurons requires CNIH-2. Also
of interest are Purkinje neurons, which express high levels of
CNIH-2 but only transiently express GluA1 (Douyard et al.,
2007). It is also worth noting that additional AMPAR auxiliary
proteins have been identified, such as CKamp44, which is
expressed in DG but not CA1 pyramidal neurons (von Engelhardt
et al., 2010). Whether a functional relationship between
CKamp44 and CNIH proteins exists in DG remains to be deter-
mined. Another interesting question is whether the ability of
CNIH proteins to influence AMPAR gating is utilized in other
types of neurons.
Conclusions
Our results reveal an intricate interplay between CNIHs and g-8
that allows for trafficking of GluA1-containing AMPARs to
synapses. Because of the selective interaction of CNIHs with
GluA1, GluA1A2 heteromers are allowed to dominate the popu-
lation of neuronal AMPARs in CA1 pyramidal neurons. GluA1A2
heteromers are required for LTP and display slower deactiva-
tion kinetics than GluA2A3 heteromers, probably allowing for
greater dendritic signal integration. Furthermore, GluA1 subunits
possess an intracellular loop and long C tails that are subject to
posttranslational modification and protein interactions that have
been shown to play roles in activity-dependent synaptic plas-
ticity. It will be of interest to know whether CNIHs themselves
are also subject to such forms of regulation and thus con-
tribute to activity-dependent trafficking and function of synaptic
GluA1-containing AMPARs. Finally, what is the structural basis
that allows CNIH and g-8 to associate with GluA1, whereas for
GluA2, g-8 prevents a functional CNIH association? Future
work toward a more complete understanding of the uniqueness
of GluA1-containing AMPARs and the mechanisms that regulate
their function will be invaluable to our understanding of how
primary neurons of numerous brain structures communicate
with one another.
EXPERIMENTAL PROCEDURES
Generation of Cnih2fl/fl and Cnih3fl/fl Mice
Cnih2fl/fl and Cnih3fl/fl mice were generated using standard procedures by
inGenious Targeting Laboratory (Ronkonkoma, NY, USA). For Cnih2fl/fl and
Cnih3fl/f mice, homologous recombination introduced loxP sites allowing for
the excision of exons 2–5 and exon 4, respectively. Both lines were crossed
to a FLP deleter line to remove the neomycin-resistance cassette.
Electrophysiology
Acute transverse 300 mm hippocampal slices were prepared from P17–P21
mice. Cultured hippocampal slices were prepared from P6–P9 mice as previ-
ously described by Schnell et al. (2002). Paired recordings of eEPSCs
involved simultaneous whole-cell recordings at room temperature from one
infected/transfected GFP-positive neuron and a neighboring GFP-negative
neuron while stimulating Schaffer collaterals. Series resistance was moni-
tored and not compensated, and cells in which series resistance was above
30 MU or varied by 25% during a recording session were discarded. mEPSCs
Neuron
CNIH Proteins Determine AMPAR Subunit Compositionwere recorded in the presence of 0.5 mM TTX. mEPSCs with an amplitude
of R5 pA and a rate of rise of R4 pA/ms were automatically detected and
analyzed offline with customized software in IGOR. Fast application of
1 mM glutamate to somatic and HEK cell outside-out patches for 1 and
100 ms by a piezoelectric controller (Siskiyou) was used to determine
AMPAR deactivation and desensitization kinetics, respectively. Our open-
tip response experiments show the 20%–80% exchange times to be less
than 200 ms.
Western Blotting, Immunoprecipitation, and Glycosidase Treatment
Adult mouse hippocampi were homogenized, and the nuclear pellet was
removed by centrifugation and resuspended in 1% Triton X-100. Precleared
lysates were incubated with antibody-bound Sepharose beads (Sigma-
Aldrich). Beads were washedwith lysis buffer and analyzed by immunoblotting
with the relevant antibodies as indicated. For glycosylation analysis, the pre-
cleared lysate was immunoprecipitated with GluA1 or GluA2 antibody and
treated with endoglycosidase Hf (Endo H) or PNGase F overnight at 37C,
resolved by SDS-PAGE, and analyzed by immunoblotting with indicated
antibodies.
Surface Immunolabeling/Imaging
Hippocampal neurons were cultured on coverslips from E18 rat hippocampus
as previously described (Roche and Huganir, 1995). The neurons were
transfected at 7 DIV. Approximately 20 days after transfection, neurons were
incubated with GluA1 antibody and then fixed. After blocking, the neurons
were incubated with the Alexa Fluor 555-conjugated secondary antibody.
The neurons were mounted and imaged under a Zeiss LSM 710 confocal
microscope.SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.neuron.2013.01.017.
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